These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28808283)

  • 1. Drug-induced Extrapyramidal Symptoms Scale (DIEPSS) Serbian Language version: Inter-rater and Test-retest Reliability.
    Peljto A; Zamurovic L; Milovancevic MP; Aleksic B; Tosevski DL; Inada T
    Sci Rep; 2017 Aug; 7(1):8105. PubMed ID: 28808283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Induced Extrapyramidal Symptoms Scale of the Norwegian version: inter-rater and test-retest reliability.
    Weidle B; Chaulagain A; Stensen K; Aleksic B; Skokauskas N; Inada T
    Nord J Psychiatry; 2019 Nov; 73(8):546-550. PubMed ID: 31532276
    [No Abstract]   [Full Text] [Related]  

  • 3. Slovenian Version of the Drug-Induced Extrapyramidal Symptoms Scale: Evaluation of Interrater and Test-Retest Reliability.
    Senica N; Aleksic B; Inada T; Iljes AP; Zamuda T; Kumperscak HG
    J Clin Psychopharmacol; 2023 Jul-Aug 01; 43(4):361-364. PubMed ID: 37104664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders.
    Kim JH; Jung HY; Kang UG; Jeong SH; Ahn YM; Byun HJ; Ha KS; Kim YS
    Mov Disord; 2002 Nov; 17(6):1354-9. PubMed ID: 12465082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study.
    Kubota C; Inada T; Lin SK; Avasthi A; Chee KY; Tanra AJ; Yang SY; Chen LY; Chong MY; Tripathi A; Kallivayalil RA; Grover S; Park SC; Kato TA; Xiang YT; Sim K; Maramis MM; Noor IM; Tan CH; Sartorius N; Shinfuku N
    Hum Psychopharmacol; 2023 Mar; 38(2):e2861. PubMed ID: 36462184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
    Favre S; Aubry JM; Gex-Fabry M; Ragama-Pardos E; McQuillan A; Bertschy G
    Encephale; 2003; 29(6):499-505. PubMed ID: 15029084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM; Cellar JS; Bowers MB; Nelson JC; Takeshita J; Zigun B
    J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity.
    Gerlach J; Korsgaard S; Clemmesen P; Lauersen AM; Magelund G; Noring U; Povlsen UJ; Bech P; Casey DE
    Acta Psychiatr Scand; 1993 Apr; 87(4):244-52. PubMed ID: 8098178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Validating the Simpson-Angus Extrapyramidal Collateral Symptom Evaluation Scale].
    Calvo-Gómez JM; Sánchez-Pedraza R; Jaramillo-González LE; Tarcisio-Mantilla C
    Rev Salud Publica (Bogota); 2006; 8(1):74-87. PubMed ID: 16703964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manual for the Extrapyramidal Symptom Rating Scale (ESRS).
    Chouinard G; Margolese HC
    Schizophr Res; 2005 Jul; 76(2-3):247-65. PubMed ID: 15949657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The longitudinal trends in the relationship between drug-induced extrapyramidal symptoms and personal and social performance in a population of the patients with schizophrenia: A latent growth model.
    Park IJ; Jung DC; Hwang SS; Jung HY; Yoon JS; Kim CE; Ahn YM; Kim YS
    Psychiatry Res; 2016 Apr; 238():33-39. PubMed ID: 27086208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent research trends in diagnosis, treatment, and prevention of drug-induced extrapyramidal symptoms seen in psychiatric patients].
    Inada T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Oct; 16(5):181-5. PubMed ID: 8962437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability, Consistency and Temporal Stability of Alberta Infant Motor Scale in Serbian Infants.
    Lackovic M; Nikolic D; Filimonovic D; Petronic I; Mihajlovic S; Golubovic Z; Pavicevic P; Cirovic D
    Children (Basel); 2020 Mar; 7(3):. PubMed ID: 32131387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyskinesia is most centrally situated in an estimated network of extrapyramidal syndrome in Asian patients with schizophrenia: findings from research on Asian psychotropic prescription patterns for antipsychotics.
    Park SC; Kim GM; Kato TA; Chong MY; Lin SK; Yang SY; Avasthi A; Grover S; Kallivayalil RA; Xiang YT; Chee KY; Tanra AJ; Tan CH; Sim K; Sartorius N; Shinfuku N; Park YC; Inada T
    Nord J Psychiatry; 2021 Jan; 75(1):9-17. PubMed ID: 32580668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Extrapyramidal Symptom Rating Scale and Its Abbreviated Version: A Critical Review of Clinimetric Properties.
    Chouinard G; Cosci F; Chouinard VA; Alphs L
    Psychother Psychosom; 2023; 92(6):359-366. PubMed ID: 38061344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter--rater and test--retest reliability of the Japanese version of the subjective deficit syndrome scale.
    Kokai M; Inada T; Ohara K; Shimizu M; Iwado H; Morita Y
    Hum Psychopharmacol; 2003 Mar; 18(2):145-9. PubMed ID: 12590409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-rater and test-retest reliability of quality assessments by novice student raters using the Jadad and Newcastle-Ottawa Scales.
    Oremus M; Oremus C; Hall GB; McKinnon MC;
    BMJ Open; 2012; 2(4):. PubMed ID: 22855629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current topics in neuroleptic-induced extrapyramidal symptoms in Japan.
    Inada T; Yagi G
    Keio J Med; 1996 Jun; 45(2):95-9. PubMed ID: 8683905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Shakuyaku-Kanzo-to on Extrapyramidal Symptoms During Antipsychotic Treatment: A Randomized, Open-Label Study.
    Ota T; Miura I; Kanno-Nozaki K; Hoshino H; Horikoshi S; Fujimori H; Kanno T; Mashiko H; Yabe H
    J Clin Psychopharmacol; 2015 Jun; 35(3):304-7. PubMed ID: 25839338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrapyramidal syndromes caused by antipsychotics.
    Jesić MP; Jesić A; Filipović JB; Zivanović O
    Med Pregl; 2012; 65(11-12):521-6. PubMed ID: 23297621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.